Sagimet Biosciences, Inc. Class A ( ($SGMT) ) just unveiled an update. On 18 December 2025, Sagimet Biosciences updated its investor presentation ...
Early Thursday, Takeda revealed top-line data for two pivotal phase 3 trials of its next-gen, highly selective oral tyrosine ...
The FDA intends to place a black box label—its most serious warning—on COVID-19 vaccines, according to reporting by CNN. It ...
Ameluz® and RhodoLED® New Drug Application (NDA) and Investigational New Drug Application (IND) have successfully been transferred to ...
Bemotrizinol, a broad-spectrum chemical sunscreen ingredient, has long been used abroad. Experts say it offers better ...
Triple-wavelength technology that can target multiple skin concerns at once ...
The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans.
From gentle light technology to advanced lasers and microneedling, The Clifford Clinic provides solutions that address skin ...
HSDD affects 40%-55% of postmenopausal women, often due to hormonal changes, impacting sexual desire and quality of life.
FDA officials are weighing a black box warning for Covid vaccines, a proposal that has drawn strong criticism from outside ...
The label is the strictest safety warning issued by the FDA, alerting healthcare providers and patients about serious or life-threatening adverse side effects.
Today, Takeda announced positive topline results from 2 pivotal phase 3 trials of zasocitinib (TAK-279; Takeda), demonstrating superiority over placebo across key efficacy end points in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results